Extendicare (0S9E) Share Forecast & Price Target
0S9E Analyst Ratings
0S9E Stock 12 Month Forecast
Average Price Target
CAD 39.20▲(47.26% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Tal Woolley | CIBC | CAD 38→CAD 40 | buy | 50.26%Upside | Reiterated | 10/26/26 | ||
 Unknown AnalystNot Ranked | National Bank | CAD 45→CAD 40 | buy | 50.26%Upside | Reiterated | 10/21/26 | ||
| Pammi Bir | RBC Capital | CAD 38→CAD 39 | buy | 46.51%Upside | Reiterated | 08/13/26 | ||
| Tom Callaghan | BMO Capital | CAD 38 | buy | 42.75%Upside | Reiterated | 08/10/26 | ||
| Jonathan Kelcher | TD Cowen | CAD 39 | buy | 46.51%Upside | Reiterated | 08/09/26 | ||
| Unknown AnalystNot Ranked | ATB Cormark Capital Markets | CAD 35→CAD 43 | buy | 61.53%Upside | Reiterated | 05/11/26 | ||
| Lorne Kalmar | Desjardins | CAD 34.50 | buy | 29.60%Upside | Initiated | 04/22/26 | ||
| Tania Armstrong-Whitworth | Canaccord Genuity | CAD 20→CAD 22.50 | buy | -15.48%Downside | Reiterated | 12/04/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Tal Woolley | 10/26/26 | CAD 38→CAD 40 | buy | 50.26%Upside | Reiterated | CIBC | ||
| Unknown AnalystNot Ranked | 10/21/26 | CAD 45→CAD 40 | buy | 50.26%Upside | Reiterated | National Bank | ||
| Pammi Bir | 08/13/26 | CAD 38→CAD 39 | buy | 46.51%Upside | Reiterated | RBC Capital | ||
| Tom Callaghan | 08/10/26 | CAD 38 | buy | 42.75%Upside | Reiterated | BMO Capital | ||
| Jonathan Kelcher | 08/09/26 | CAD 39 | buy | 46.51%Upside | Reiterated | TD Cowen | ||
| Unknown AnalystNot Ranked | 05/11/26 | CAD 35→CAD 43 | buy | 61.53%Upside | Reiterated | ATB Cormark Capital Markets | ||
| Lorne Kalmar | 04/22/26 | CAD 34.50 | buy | 29.60%Upside | Initiated | Desjardins | ||
| Tania Armstrong-Whitworth | 12/04/25 | CAD 20→CAD 22.50 | buy | -15.48%Downside | Reiterated | Canaccord Genuity |
Best Analysts Covering Extendicare
Copying PerPlexity Health Care CA's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +9.45% per trade.
Copying PerPlexity Health Care CA's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +16.25% per trade.
Copying PerPlexity Health Care CA's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +16.25% per trade.
0S9E Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 4 | 4 | 6 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 4 | 4 | 6 | 2 |
In the current month, 0S9E has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0S9E average Analyst price target in the past 3 months is 39.20.
0S9E Financial Forecast
0S9E Earnings Forecast
Next quarter’s earnings estimate for 0S9E is CAD 0.36 with a range of CAD 0.35 to CAD 0.36. The previous quarter’s EPS was CAD 0.32. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
0S9E Sales Forecast
Next quarter’s sales forecast for 0S9E is CAD 635.88M with a range of CAD 595.30M to CAD 706.50M. The previous quarter’s sales results were CAD 611.04M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
